GoAI
Get started
Care Twentyone Corporation logo

Care Twentyone Corporation

2373.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥410

+¥1.00 · +0.24%

Aug 24, 3:30 PM JST

2373.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Care Twentyone Corporation operates as a comprehensive welfare company in Japan. The company offers home care, paid nursing home, dementia group home, in-home care support, small-scale multi-functional home care, day service, and welfare equipment rental/home renovation services. It also provides support services for people with disabilities; and childcare, home nursing care, home nursing care, medical support, acupuncture and massage, human resource placement and dispatch, lifestyle support, dinning, real estate, and Type A and Type B continuous employment support, as well as employment services for people with disabilities. In addition, the company operates nursing qualification training schools. Care Twentyone Corporation was incorporated in 1993 and is headquartered in Osaka, Japan.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Yasuhiro Yoda
Listed since
Oct 17, 2003
Employees
6,319

Market position

Volume
5.3K
0.4× average
Average volume
13.11K
Average daily volume
Market cap
5.55B JPY
Beta
0.13
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
20.82B JPY
P/E (TTM)
52.63×
P/B (TTM)
1.33×
P/S (TTM)
0.11×
EV / EBITDA
9.62×
Earnings yield
5.96%
Free cash flow yield
31.41%
Dividend yield
4.15%

Profitability & efficiency

Gross margin
23.67%
Operating margin
2.28%
Net margin
0.21%
Return on equity
8.69%
Return on assets
1.20%
Return on invested capital
2.10%

Financial health

Debt / equity
4.62×
Current ratio
1.05×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends26%16%6%-3%Gross margin, FY2021: 23.41%Gross margin, FY2022: 23.36%Gross margin, FY2023: 20.95%Gross margin, FY2024: 20.25%Gross margin, FY2025: 22.05%Operating margin, FY2021: 4.14%Operating margin, FY2022: 2.89%Operating margin, FY2023: -0.98%Operating margin, FY2024: -1.01%Operating margin, FY2025: 1.63%Net margin, FY2021: 2.58%Net margin, FY2022: 1.64%Net margin, FY2023: 0.01%Net margin, FY2024: 0.61%Net margin, FY2025: 0.80%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 23.41%. Gross margin FY2022 23.36%. Gross margin FY2023 20.95%. Gross margin FY2024 20.25%. Gross margin FY2025 22.05%. Operating margin FY2021 4.14%. Operating margin FY2022 2.89%. Operating margin FY2023 -0.98%. Operating margin FY2024 -1.01%. Operating margin FY2025 1.63%. Net margin FY2021 2.58%. Net margin FY2022 1.64%. Net margin FY2023 0.01%. Net margin FY2024 0.61%. Net margin FY2025 0.80%.

Income trends

Revenue

48.16B JPY+6.08%

Operating income

784.94M JPY+1.25B JPY

Net income

384.18M JPY+37.98%
Income trends across reported periods53.02B JPY33.57B JPY14.12B JPY−5.32B JPYRevenue, FY2021: 36.36B JPYRevenue, FY2022: 38.4B JPYRevenue, FY2023: 41.1B JPYRevenue, FY2024: 45.4B JPYRevenue, FY2025: 48.16B JPYOperating income, FY2021: 1.51B JPYOperating income, FY2022: 1.11B JPYOperating income, FY2023: −401.04M JPYOperating income, FY2024: −460.65M JPYOperating income, FY2025: 784.94M JPYNet income, FY2021: 937.08M JPYNet income, FY2022: 630.49M JPYNet income, FY2023: 6.16M JPYNet income, FY2024: 278.42M JPYNet income, FY2025: 384.18M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 36.36B JPY. Revenue FY2022 38.4B JPY. Revenue FY2023 41.1B JPY. Revenue FY2024 45.4B JPY. Revenue FY2025 48.16B JPY. Operating income FY2021 1.51B JPY. Operating income FY2022 1.11B JPY. Operating income FY2023 −401.04M JPY. Operating income FY2024 −460.65M JPY. Operating income FY2025 784.94M JPY. Net income FY2021 937.08M JPY. Net income FY2022 630.49M JPY. Net income FY2023 6.16M JPY. Net income FY2024 278.42M JPY. Net income FY2025 384.18M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue48.16B JPY45.4B JPY41.1B JPY38.4B JPY36.36B JPY
Cost of goods sold37.54B JPY36.2B JPY32.49B JPY29.43B JPY27.85B JPY
Gross profit10.62B JPY9.19B JPY8.61B JPY8.97B JPY8.51B JPY
Selling, general, and administrative3.69B JPY8.76B JPY8.21B JPY7.18B JPY6.42B JPY
Operating expenses9.84B JPY9.65B JPY9.01B JPY7.86B JPY7.01B JPY
Interest income19.26M JPY22.3M JPY23.58M JPY14.42M JPY15.32M JPY
Interest expense487.85M JPY474.43M JPY621.1M JPY632.14M JPY662.52M JPY
Depreciation and amortization1.38B JPY1.4B JPY1.6B JPY1.47B JPY1.4B JPY
Operating income784.94M JPY−460.65M JPY−401.04M JPY1.11B JPY1.51B JPY
Net income384.18M JPY278.42M JPY6.16M JPY630.49M JPY937.08M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-27.79

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates32.5210.93-10.67-32.26Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Q3 2024, reported Sep 13, 2024: actual 27.46, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 14, 2024: actual 28.05, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 14, 2025: actual -6.15, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 13, 2025: actual 3.62, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 19.29, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 31, 2025: actual 11.68, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 13, 2026: actual 4.63, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Jun 12, 2026: actual -27.79, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates13.12B12.46B11.81B11.15BQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Q3 2024, reported Sep 13, 2024: actual 11.66B JPY, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 14, 2024: actual 11.79B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 14, 2025: actual 11.81B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Jun 13, 2025: actual 11.81B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 12.3B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 31, 2025: actual 12.24B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 13, 2026: actual 12.19B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Jun 12, 2026: actual 12.62B JPY, estimate —, surprise —, Comparison unavailable.

2373.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 2373.T

research.disclaimer